There is a gap in AI innovation between pediatric and adult medicine, with pediatrics lagging behind, experts said.
Three pediatric physicians discussed the current and future uses of AI in pediatrics during a Healio Community webinar. James S. Barry, MD, MBA, medical director of the level III neonatal ICU, professor of neonatology at Children’s Hospital Colorado and cofounder of NeoMIND-AI, led the discussion with Clara Lin, MD, and Ryan McAdams, MD.
All three speakers agreed that AI adoption is slow in pediatrics and shared several reasons why.
McAdams, a neonatal intensivist at University of

Recent claims about prenatal acetaminophen causing adverse neurodevelopmental effects in offspring may have led to changes in prescribing patterns despite the lack of scientific evidence and no updates to clinical recommendations, data show.
Last year, the FDA began notifying physicians of an apparent risk for autism in youths whose mothers used acetaminophen (also known as paracetamol), the main ingredient in Tylenol (Kenvue), during pregnancy.
Federal officials announced during a White House briefing on Sept. 22, 2025, that the FDA would start the process of updating the label of

Apixaban conferred lower bleeding risk during a 3-month period compared with rivaroxaban in patients with acute venous thromboembolism, researchers reported.
Despite higher medication adherence to rivaroxaban than to apixaban and similar rates of mortality and serious adverse events unrelated to bleeding or venous thrombosis, the present trial does not explain the reported difference in clinically relevant bleeding between the two medications, according to the study.
The results of the prospective, randomized, open-label, masked endpoint, international COBRRA trial were published in The New

The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release from Johnson & Johnson.
A previous analysis of the lens found that 97% of patients reported “no very bothersome visual disturbances,” with 97% of patients reporting that they would recommend the IOL to friends and family.
According to the release, this is the first FDAapproved extended depth of focus IOL with no warning on loss of contrast sensitivity. In addition, it reduces the impact of presbyopia and reliance on glasses after surgery. The IOL provides “excellent

Pyoderma gangrenosum is a difficult-to-treat wound disease that may soon have promising new therapies.
In this Beneath the Surface video interview, Joel M. Gelfand, MD, MSCE, FAAD, the James J. Leyden Professor of Clinical Investigation and professor of dermatology and epidemiology at University of Pennsylvania’s Perelman School of Medicine and Healio Dermatology’s Chief Medical Editor, spoke with Robert S. Kirsner, MD, PhD, chairman and professor at the department of dermatology and cutaneous surgery at University of Miami Miller School of Medicine, director of the University of Miami

Years of playing football can worsen cognition later in life, with factors like inflammation serving as a pathway, according to two recently published studies.
Such findings can help “improve earlier detection and identify who is at greatest risk before too much brain change has occurred,” Breton Asken, PhD, one of the studies’ co-authors and an assistant professor and neuropsychologist in the department clinical and health psychology at the University of Florida, said in a press release.
One of the analyses, published in JAMA Network Open, indicated that the levels and years of football play

Exercise may reduce cancer-related cognitive impairment among people starting chemotherapy, according to results of a randomized phase 3 trial.
Patients assigned to a home-based program of low- to moderate-intensity exercise also reported less mental fatigue than those who received usual care.
The findings suggest simple, safe forms of physical activity could be a valuable component of supportive care during treatment, researchers concluded.
“This really stresses the importance that patients avoid inactivity at all costs and, if possible, try to maintain their pretreatment activity levels,”

Girls who have more problems sleeping during childhood and adolescence are more likely to have polycystic ovary syndrome at age 14 years than those with fewer issues sleeping, researchers reported.
In a paper published in The Journal of Clinical Endocrinology & Metabolism, researchers assessed sleep behaviors of 226 female children and adolescents, with sleep outcomes reported by parents or guardians. Researchers found that girls diagnosed with PCOS at age 14 years had worse sleep behaviors during childhood than those not diagnosed with PCOS, with the gap in sleep behavior scores between

Adults with intellectual and developmental disabilities reported more anxiety and depression, more treatment use and greater barriers to care than adults without these limitations, according to a study published in JAMA Network Open.
These results indicate a need for services and policies informed by these disparities, Dimitri A. Christakis, MD, MPH, professor of pediatrics and epidemiology, University of Washington, and colleagues wrote.
“People with IDD suffer from preventable and treatable health conditions that are unaddressed,” Christakis, who also is chief health officer of Special

KANSAS CITY, Mo. — The End-Stage Renal Disease Treatment Choices model provided critical lessons about financial incentives and access to care for future value-based kidney care models, a speaker said during the Annual Dialysis Conference.
In her presentation, Suzanne Watnick, MD, FASN, professor of medicine at University of Washington, Seattle, and American Society of Nephrology health policy scholar in residence, outlined lessons from the most recent payment models in nephrology and the future kidney care policy landscape.
“I thought it was important not just to talk about that model, but